After the decline Fibrocell Science Inc.(OTC:FCSC) stock has settled around $0.6 per share. There are the optimistic dates, there are also the other type shorters are looking for. Last week, however, was one of increased activity. Not the usual type, though. 
The usual type of activity is when traders act. Last week was the one when the company’s public relations division was the most active player. Press releases, one after another, were coming on a daily basis. As it seems, it is not over yet, since the last press release came too late on Friday; thus it had little chance of affecting the stock market. An easy fix – the same announcement just came in, so that a second shot at affecting traders is granted.
Now, speaking of effects of the company’s announcements last week, they obviously pushed the share price higher. Monday closed at $0.58 per share, Friday did at $0.67 per share. As strange as it might seem, there was not much trading activity. In fact, if one had to judge simply by looking at the chart, he would have difficulties guessing that so much press releases came out, given the low trading volumes.
The above, however, is not exactly unusual for Fibrocell Science. The quarterly statements are a perfect example. The last 10-Q came out in the middle of August, and despite some interesting figures in it, there was neither any major difference in trading activity, nor any changes in the share price that would focus additional attention on the stock. In fact, even promotions from previous months failed to inspire traders to form a new all-time high in trading volume. [BANNER]
All of the above in mind, it would appear that traders are waiting for something different. Not financing arrangements, not short-term opportunities. Something, that could inspire confidence in them that FCSC could achieve sustainable growth in the stock market. Until this actually happens, it is uncertainty more than anything else that would determine the development of this stock.
